Target intelligence / Profile preview

Amelogenin X-linked (AMELX)

Target
AMELX
Molecular classification
Extracellular matrix protein, Other
01

Overview

Amelogenin X-linked (AMELX) is a gene encoding the major form of the protein amelogenin, an extracellular matrix protein essential for the formation of tooth enamel[1][2][3][4][5][6]. Amelogenin comprises about 90% of the protein in developing enamel and is responsible for the regulation, organization, and mineralization of enamel crystallites during tooth development, ensuring proper enamel structure and strength[1][2][3][5]. Mutations in AMELX cause X-linked forms of amelogenesis imperfecta, a group of inherited conditions characterized by abnormally formed or hypomineralized enamel, which can result in fragile, discolored, or grooved teeth[2][4][5]. Although AMELX primarily functions in enamel, lower levels are also found in other tissues, but their biological significance there is not fully understood[5]. AMELX is not considered a direct drug target, and there are no known drugs acting on this protein. However, AMELX status is a useful genetic biomarker for certain dental disorders and for sex determination in forensic analysis.

Other names
Amelogenin, X isoformAMGAMGXamelogenesis imperfecta 1AI1EAIH1ALGNAMGLamelogenin (amelogenesis imperfecta 1, X-linked)amelogenin (X chromosome, amelogenesis imperfecta 1)AMELX_HUMAN
02

Biological functions

Tooth enamel biomineralizationStructural constituent of enamelRegulation of crystallite formation in enamelEnamel mineralizationTooth development (odontogenesis)Possibly minor roles in bone, bone marrow, and brain cells (function unknown)
03

Disease associations

Amelogenesis imperfecta (X-linked and other forms)Other enamel defects
04

Biomarkers

AMELX mutational status can be used to diagnose X-linked amelogenesis imperfecta and to differentiate between X and Y chromosome material in forensic or diagnostic PCR assays

Beyond the preview

Go deeper on Amelogenin X-linked (AMELX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amelogenin X-linked (AMELX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call